Results for this period
Third quarter1 January 2026 to 30 September 2026ConsolidatedIFRSThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Revenue grew as a result of expanding the product lineup, rolling out proprietary products, marketing investment and shifting resources to growth channels such as e-commerce. Pet care grew particularly strongly, mainly in North America. Meanwhile, the delayed recovery from reputational damage in China and the impact of soaring raw material prices weighed on profit.
No applicable matters
| Item | Details |
|---|---|
| Fiscal Period Classification | Third quarter |
| Accounting standards | IFRS |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 January 2026 to 30 September 2026 |
| Net Sales | ¥729,342 million (YoY +5.1%) |
| Operating profit | ¥89,467 million (core operating profit) (YoY +3.3%) |
| Ordinary income | ¥92,826 million (profit before tax for the quarter) (YoY -0.7%) |
| Profit attributable to owners of the parent | ¥56,733 million (YoY -6.6%) |
| Net income per share | ¥32.88 |
| Equity ratio | End of the current fiscal period 65.7 / End of previous period 65 |
| Total assets | ¥1,211,069 million |
| Net assets | ¥892,552 million (total equity) |
| Cash flows from operating activities | ¥77,927 million |
| Cash flows from investing activities | ¥-32,587 million |
| Cash flows from financing activities | ¥-66,040 million |
| Cash and cash equivalents at end of period | ¥232,538 million |
| Full-year earnings forecast | Net Sales ¥1,015,000 million (YoY +7.4%) / Operating profit ¥113,000 million (core operating profit) (YoY +3.8%) / Ordinary income ¥113,500 million (profit before tax) (YoY +7.7%) / Net income ¥70,000 million (profit attributable to owners of the parent) (YoY +7.3%) |
| Annual Dividend Forecast | 18 Yen → 22 Yen（+22.2%） |
| Segment revenue | Personal Care ¥590,366 million (YoY +3.4%), Pet Care ¥127,807 million (YoY +13.0%), Other ¥11,169 million (YoY +8.2%) |
| Segment profit | Personal Care ¥66,436 million (core operating profit) (YoY 0.0%), Pet Care ¥21,709 million (core operating profit) (YoY +12.4%), Other ¥1,322 million (core operating profit) (YoY +46.6%) |
| Depreciation and amortization | ¥35,214 million (depreciation and amortization) |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement Not disclosed |
| Changes in the scope of consolidation | New Number of companies 2 / Company name Nutrire Industria de Alimentos Ltda., SOFY UNICHARM EAST AFRICA LIMITED / Excluded Number of companies 0 / Company name Not disclosed |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Whether applicable Yes / Subject person Securities analysts and institutional investors |
| Issued Shares at Period-End | 1,862,502,957 |
| Treasury Shares at Period-End | 141,702,640 |
| Factors Behind Changes in Business Performance | Revenue grew as a result of expanding the product lineup, rolling out proprietary products, marketing investment and shifting resources to growth channels such as e-commerce. Pet care grew particularly strongly, mainly in North America. Meanwhile, the delayed recovery from reputational damage in China and the impact of soaring raw material prices weighed on profit. |
Items this document does not state (9)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company cites the rollout of a broad product lineup, marketing investment, a shift in resources to growth channels such as e-commerce, and growth in its pet care business. Meanwhile, it says that a delayed recovery from reputational damage in China, soaring raw material prices, inflation and a slowdown in the Asian economy restrained the recovery in profit.